NYU Langone and NYU Grossman in the News
Ron Bennington talks hosting comedy podcast during chemo
TODAY
Comedian and radio host Ron Bennington, who is undergoing treatment for colorectal cancer, discussed his comedy podcast aimed at spreading laughs and hope. He was joined by Mark B. Pochapin, MD, senior vice president and senior associate dean of institutional advancement and special projects, vice chair of clinical affairs for the Department of Medicine, director of gastroenterology and hepatology at NYU Langone Health, and a host on Sirius XM's Doctor Radio. Dr. Pochapin commented on the importance of relationships for health and emphasized that humor is a crucial vehicle for enduring difficult times.
Also reporting was: Yahoo, Aol, TV Insider, Cadillac News
10/07/2026
Doctor shares tips for Breast Cancer Awareness Month
Spectrum News NY1
In an interview, Elizabeth Comen, MD, breast oncologist and co-director of the Mignone Women’s Health Collaborative at NYU Langone Health, discussed strategies for predicting and detecting breast cancer. She noted that mortality rates have significantly declined due to improved screening and more targeted treatments. Dr. Comen highlighted the rise of cancer in younger women as a complex area of research, potentially linked to lifestyle factors like processed foods and alcohol. She also mentioned advancements such as using artificial intelligence to enhance mammograms and ongoing discussions about whether the screening age for certain populations should be lowered from 40.
10/07/2026
I made an innocent mistake on an international flight — my eyesight may never be the same again
New York Post
A first-person account details a writer's experience developing a corneal ulcer after misusing contact lenses during international travel. The writer was treated at New York Eye and Ear Infirmary of Mt. Sinai. Kathryn A. Colby, MD, PhD, chair of the Department of Ophthalmology at NYU Grossman School of Medicine, comments on the condition, explaining that when a break occurs in the cornea's protective barrier, it leaves the eye vulnerable to infection. Dr. Colby notes that while the cornea is hardy, taking this resilient tissue for granted is not worth the risk.
Also reporting was: USTimes Mirror, Aol
10/07/2026
Detecting heart rejection without biopsy after transplant
Reuters
Researchers have developed an artificial intelligence model that can improve the detection of heart transplant rejection without surgery, proving more accurate than standard blood tests. A study led by Lior Jankelson, MD, PhD, an associate professor in the Department of Medicine at NYU Grossman School of Medicine, trained an AI model using electrocardiography readings and blood test results. In a test group, the model correctly identified 100% of patients not experiencing rejection, which could prevent unnecessary biopsies. Dr. Jankelson noted the results highlight that electrocardiograms contain abundant physiological information that can substantially improve accuracy and enable earlier diagnosis for patients.
10/07/2026
IGHV and TP53 status in choosing fixed-duration vs continuous therapy
OncLive
In a discussion about selecting therapy for chronic lymphocytic leukemia (CLL), Marc J. Braunstein, MD, PhD, associate professor of medicine at NYU Grossman Long Island School of Medicine, stated his preference for continuous therapy for patients with unmutated IGHV and TP53-aberrant disease. He favors either single-agent acalabrutinib or zanubrutinib, or a Bruton tyrosine kinase (BTK) inhibitor combined with an anti-CD20 antibody. Dr. Braunstein also noted that while measurable residual disease testing may eventually guide treatment withdrawal, these specific patient groups currently represent an unmet need.
10/07/2026
Why infection rates are similar across BTK inhibitors
OncLive
In a discussion on Bruton tyrosine kinase (BTK) inhibitors for chronic lymphocytic leukemia (CLL), experts question why infection rates are similar across different covalent drugs. Marc J. Braunstein, MD, PhD, associate professor of medicine at NYU Grossman Long Island School of Medicine, explains that although second-generation agents are more specific, all act on the same B-cell receptor pathway. This process reduces the function of the healthy B-cell compartment, lowering humoral immunity. He suggests the advantages of newer agents lie in other areas, such as reduced rates of atrial fibrillation.
10/07/2026
Comparing sotorasib and adagrasib tolerability
OncLive
Rajwanth Veluswamy, MD, clinical associate professor of medicine at NYU Grossman School of Medicine, and Chinmay Jani, MD, of the University of Miami Sylvester Comprehensive Cancer Center, compared the tolerability of sotorasib and adagrasib in KRAS G12C-mutated non-small cell lung cancer. Veluswamy noted adagrasib has greater gastrointestinal toxicity while sotorasib has more hepatotoxicity, an important factor for patients who have received immunotherapy. Both physicians support shared decision-making, favoring these better-tolerated oral drugs over chemotherapy and recommending clinical trials first when available.
10/07/2026
Emerging KRAS G12C inhibitors in development
OncLive
Rajwanth Veluswamy, MD, clinical associate professor of medicine at NYU Grossman School of Medicine, discusses emerging KRAS G12C-directed agents for non-small cell lung cancer. Along with a physician from the University of Miami Sylvester Comprehensive Cancer Center, he highlights divarasib and olomorasib as more potent inhibitors showing improved response rates. He also describes daraxonrasib, a multi-selective RAS inhibitor that targets KRAS in its active state to address drug resistance. In recent findings, daraxonrasib produced a response rate near 40% and a progression-free survival of 8.3 months.
10/07/2026
GLP-1 weight-loss drug prescriptions for young kids skyrocketing, study finds
Activist Post
A study from researchers at NYU Langone Health found that prescriptions of GLP-1 weight-loss drugs for children ages 8 to 11 have surged 310-fold since 2019. Babak J. Orandi, MD, PhD, an obesity specialist and associate professor of surgery and medicine at NYU Grossman School of Medicine, and the study's lead investigator, stated the research provides the first national look at how these drugs are used in young children. Orandi expressed concern that medication treats individual cases but fails to address environmental factors driving childhood obesity. The FDA has not approved the drugs for children under 12, so their use is off-label.
10/07/2026
Taking antibiotics? Sugar may be making the damage worse
ScienceDaily
A study by researchers from NYU Langone Health, City of Hope, and Memorial Sloan Kettering found that consuming sugar can worsen gut microbiome damage from antibiotics. Published in Nature, the research on cancer patients revealed that for every 100 grams of sugar eaten before treatment, beneficial bacterial diversity declined by an additional 21%. According to co-senior author Jonas Schluter, PhD, assistant professor in the Department of Microbiology at NYU Grossman School of Medicine, reducing sugar intake during antibiotic treatment could help limit these health risks. The findings also linked sugary diets with increases in the potentially dangerous Enterococcus faecium bacteria.
Also reporting was: WDC News 6, LabRoots
10/07/2026
Natera (NTRA) launches melanoma clinical trial leveraging Signatera technology
GuruFocus
On 7 October 2026, Natera Inc announced the start of a new clinical trial for advanced and metastatic melanoma, with initial patient enrollments underway. The study, which is supported by NYU Langone Health, uses Natera’s Signatera molecular residual disease test to help improve treatment timing and precision. The test is designed to detect circulating tumor DNA to identify residual disease before it is clinically visible. The article also provides a detailed financial analysis of Natera, noting its high market valuation, strong growth metrics, and significant insider selling over the past year.
Also reporting was: Markets Insider
10/07/2026
Study finds a whole grain sweet spot for heart health
The Seattle Times
A recent meta-analysis in the European Heart Journal suggests that increased whole grain consumption can improve several risk factors for cardiovascular disease. The study found the greatest benefits at an intake of 60 to 100 grams per day. Commenting on the findings, Lourdes Castro, registered dietitian and culinary medicine and nutrition lead at NYU Langone's Griffin Healthspan and Vitality Center, said that increasing whole grains is a practical goal and she encourages consuming grains in their intact form, such as oatmeal or quinoa, rather than processed foods made with whole grain flour.
10/07/2026
Video: Retatrutide demonstrates significant weight loss in Type 2 diabetes in TRIUMPH-2 trial
Endocrinology Advisor
Rachel Pessah-Pollack, MD, endocrinologist and clinical professor of medicine at NYU Langone Health, commented on the TRIUMPH-2 trial results for retatrutide, a new drug for patients with obesity and type 2 diabetes. She described the findings as a 'game changer,' noting the trial showed nearly 20% weight loss and significant A1C reduction. Dr. Pessah-Pollack explained that retatrutide is a triple hormone agonist, which differs from current treatments. She also emphasized the drug is not yet FDA-approved and that more data from direct comparator trials will be important for future clinical use.
10/07/2026
NIH awards NYU team $3.3M for neurosurgery digital PCR platform
GenomeWeb
A team of engineers and surgeons at NYU Grossman School of Medicine has been awarded a $3.3 million grant from the National Institutes of Health. The funding is designated to advance a digital PCR-based tumor cell assessment platform for use during brain surgeries. This new award expands on existing research by including the development of an automated version of the platform.
10/07/2026
The best time to eat dinner for better metabolism and sleep, according to science
Health
A growing body of research indicates that eating dinner earlier benefits metabolism and sleep, as late meals can cause blood sugar spikes and reduce fat processing. Scientists suggest the hormone melatonin, which rises at night, may interfere with the body's ability to regulate blood sugar. Collin J. Popp, PhD, assistant professor in the Department of Population Health at NYU Grossman School of Medicine, recommends eating dinner between 5 p.m. and 7 p.m. and making dinner smaller than other daily meals. He also suggests that prioritizing protein and fiber earlier in the day can help curb evening hunger.
Also reporting was: Aol
10/07/2026
Why is U.S. Physical Therapy (NYSE:USPH) broadening its care network?
Kalkine Media USA
U.S. Physical Therapy is expanding its care network through hospital affiliations, including a strategic alliance between its subsidiary, Metro Physical & Aquatic Therapy, and NYU Langone Health. This arrangement connects a network of existing outpatient clinics with NYU Langone's clinical services network across Long Island and the New York metropolitan area. The integration is being implemented in phases and is scheduled to be completed by the end of the year. These hospital relationships are a key component of the company's recent operational developments, connecting established therapy locations with broader clinical networks.
10/07/2026
Medscape
In a conversation on trust in medicine, Lauren Taylor, PhD, assistant professor in the Department of Population Health at NYU Grossman School of Medicine, discussed the crisis of trust in healthcare. She emphasized distinguishing between trust and trustworthiness, arguing that clinicians must first be deserving of trust. Taylor also suggested that trust has not vanished but has been redistributed to new sources. The discussion also covered how organizational factors can shape a patient's trust, the role of commercial interests in healthcare, and strategies for navigating patient use of AI for medical information.
10/07/2026
Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”
The Cancer Letter
In an interview recapping his first year as Director of the National Cancer Institute, Anthony Letai discussed efforts to improve clinical trial competitiveness in the United States. Letai highlighted cancer centers that have successfully streamlined processes, citing NYU Langone's Perlmutter Cancer Center as a 'great example' that has cut its activation times by at least half. The conversation also covered the NCI's record-high extramural funding, contradicting reports of cuts, and outlined priorities including functional precision medicine, therapeutic cancer vaccines, and the use of artificial intelligence in oncology.
10/07/2026
Phys.org
A new study by researchers, including from NYU Grossman School of Medicine, found that workers in commercial kitchens with gas and propane appliances can be exposed to heat and air pollution at levels exceeding health guidelines. Published in Environmental Research Letters, the research compared gas and all-electric kitchens and found approximately 70% of gas kitchens surpassed the EPA's one-hour standard for nitrogen dioxide during working hours. All-electric kitchens were found to be cooler and cleaner. The study also highlighted that pilot lights contribute to elevated pollution levels overnight when ventilation is often off.
10/07/2026
Fruit fly study reveals how neural gates switch on short-term memory
Medical Xpress
A study in fruit flies led by researchers at NYU Langone Health has confirmed how the brain encodes short-term memories. Published in Nature, the research identified a 'split attractor network' that provides the necessary stability and flexibility for working memory by gating communication between two neuron types. This system allows a fly to temporarily remember the direction of a scent. According to senior investigator Katherine Nagel, PhD, an associate professor in the Department of Neuroscience at NYU Grossman School of Medicine, the experiments confirm long-held assumptions about how such memory circuits function.
Also reporting was: MSN India, Neuro Science News
10/07/2026
Immune protein CD37 blocks leg muscle healing in artery disease
SCIENMAG
Research from the Cardiovascular Research Center of NYU Grossman School of Medicine suggests the immune protein CD37 blocks muscle healing in peripheral artery disease. The study, published in the Journal of Translational Medicine, found elevated CD37 expression in muscle samples from patients with PAD. In mouse models, animals lacking CD37 demonstrated significantly faster revascularization and muscle regeneration following injury. The findings indicate that removing CD37 shifts inflammatory cells toward a healing state, offering a potential therapeutic target to improve recovery for patients with this common vascular condition.
10/07/2026
The Sun
The article discusses 'ghost poos,' or bowel movements that leave no residue, as a potential indicator of good gut health and a lower risk of pancreatic cancer. These stools often signify a diet rich in fiber. Rabia A. De Latour, MD, associate professor of medicine at NYU Grossman School of Medicine, comments that a well-formed bowel movement that sinks and leaves no trace is indicative of a very healthy bowel movement. The article contrasts this with symptoms of pancreatic cancer, which can include pale and oily stools.
10/07/2026
